CAM 17.1--a new diagnostic marker in pancreatic cancer.

Por Gansauge, F., Gansauge, S., Parker, N., Beger, M. I., Poch, B., Link, K. H., Safi, F., Beger, H. G.
Publicado em 1996

Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α

Por Kornmann, M, Staib, L, Wiegel, T, Kreuser, E-D, Kron, M, Baumann, W, Henne-Bruns, D, Link, K-H
Publicado em 2010

Riboswitches in Eubacteria Sense the Second Messenger Cyclic Di-GMP

Por Sudarsan, N., Lee, E. R., Weinberg, Z., Moy, R. H., Kim, J. N., Link, K. H., Breaker, R. R.
Publicado no Science (2008)

Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial

Por Tikidzhieva, A, Benner, A, Michel, S, Formentini, A, Link, K-H, Dippold, W, von Knebel Doeberitz, M, Kornmann, M, Kloor, M
Publicado em 2012